Red Sox pitcher Steven Wright will miss the first half of the 2019 season after testing positive for a performance-enhancing substance, according to an announcement from the MLB.
Wright tested positive for a substance called Growth Hormone Releasing Peptide 2, shortened to GHRP-2.
Red Sox pitcher Steven Wright suspended 80 games by @MLB after testing positive for a performance-enhancing substance, Growth Hormone Releasing Peptide 2 (GHRP-2), according to a league announcement. @MLBNetwork— Jon Morosi (@jonmorosi) March 6, 2019
In a statement, the Red Sox said they fully support the league's Joint Drug Prevention and Treatment Program and its efforts to eliminate performance-enhancing substances from baseball.
"While we are disappointed by the news of this violation, we will look to provide the appropriate support to Steven at this time," the team wrote. "Going forward, the club will not comment further on the matter."
Wright said in a statement issued through the Major League Baseball Players Association that he learned of the positive test during the offseason.
"Although I do not dispute the validity of the test, I was shocked as I have never intentionally ingested anything for performance-enhancing purposes," the statement said. "I have fully cooperated with MLB and will continue to try and identify the source of the result."
Wright is ineligible to play in any postseason games this year and he will lose about half of his salary of $1,375,000. Last year's suspension cost him $94,624 of his $1.1 million salary.
Wright had also been suspended in 2018 in connection with a domestic assault case. He was arrested on Dec. 8, 2017, at his home outside of Nashville, Tennessee, and charged with domestic related assault and prevention of a 911 call, both misdemeanors.
In 2018, Wright pitched in 20 games, compiling a 3-1 record with a 2.68 ERA and one save.
He's 24-15 in his career with a 3.77 career ERA.
The Associated Press contributed to this report.
© 2019 Cox Media Group.